Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.

Klastersky, J; de Naurois, J; Rolston, K; Rapoport, B; Maschmeyer, G; Aapro, M; Herrstedt, J

Klastersky, J; de Naurois, J; Rolston, K; Rapoport, B; Maschmeyer, G; Aapro, M; Herrstedt, J.

Afiliación

Klastersky J; Institut Jules Bordet-Centre des Tumeurs de l'ULB, Brussels, Belgium.
de Naurois J; St Luke's Cancer Centre, Royal Surrey County Hospital, Guildford, UK.
Rolston K; M.D. Anderson Cancer Center, Houston, TX, USA.
Rapoport B; Medical Oncology Centre of Rosebank, Johannesburg, South Africa.
Maschmeyer G; Department of Hematology, Oncology and Palliative Care, Ernst von Bergmann Hospital, Potsdam, Germany.
Aapro M; Multidisciplinary Institute of Oncology, Clinique de Genolier, Genolier, Switzerland.
Herrstedt J; Department of Oncology, Odense University Hospital (OUH), Odense, Denmark.

Ann Oncol ; 27(suppl 5): v111-v118, 2016 Sep.

Article en En | MEDLINE | ID: mdl-27664247

Buscar en Google

Imprimir

XML

PubMed Links

Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Bélgica

Buscar en Google

Imprimir

XML

PubMed Links